The Accumulation of Phenyllactic Acid Impairs Host Glutamine Metabolism and Inhibits African Swine Fever Virus Replication: A Novel Target for the Development of Anti-ASFV Drugs

Junfei Dai,Xusheng Ma,Ashenafi Kiros Wubshet,Qian Li,Xiaofen Shang,Zhikuan Luo,Jianan Liu,Zhiyu Li,Mingxia Li,Yujie Song,Lijun Guo,Jie Zhang,Haixue Zheng
DOI: https://doi.org/10.3390/v16030449
2024-03-14
Viruses
Abstract:African swine fever (ASF) is a highly contagious and hemorrhagic disease caused by infection with the African swine fever virus (ASFV), resulting in a mortality rate of up to 100%. Currently, there are no effective treatments and commercially available vaccines for ASF. Therefore, it is crucial to identify biochemicals derived from host cells that can impede ASFV replication, with the aim of preventing and controlling ASF. The ASFV is an acellular organism that promotes self-replication by hijacking the metabolic machinery and biochemical resources of host cells. ASFV specifically alters the utilization of glucose and glutamine, which are the primary metabolic sources in mammalian cells. This study aimed to investigate the impact of glucose and glutamine metabolic dynamics on the rate of ASFV replication. Our findings demonstrate that ASFV infection favors using glutamine as a metabolic fuel to facilitate self-replication. ASFV replication can be substantially inhibited by blocking glutamine metabolism. The metabolomics analysis of the host cell after late-stage ASFV infection revealed a significant disruption of normal glutamine metabolic pathways due to the abundant expression of PLA (phenyllactic acid). Pretreatment with PLA also inhibited ASFV proliferation and glutamine consumption following infection. The metabolomic analysis also showed that PLA pretreatment greatly slowed down the metabolism of amino acids and nucleotides that depend on glutamine. The depletion of these building blocks directly hindered the replication of ASFV by decreasing the biosynthetic precursors produced during the replication of ASFV's progeny virus. These findings provide valuable insight into the possibility of pursuing the development of antiviral drugs against ASFV that selectively target metabolic pathways.
virology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is how the changes in host cell metabolic pathways during African Swine Fever Virus (ASFV) infection affect virus replication. Specifically, the researchers focused on the roles of two metabolites, glucose and glutamine, in ASFV replication and whether ASFV replication could be inhibited by modulating these metabolic pathways. The main objective of the paper was to explore the effect of phenyllactic acid (PLA) on host glutamine metabolism and its potential as a new anti - ASFV drug target. The research background of the paper indicates that African swine fever is a highly contagious and hemorrhagic disease caused by ASFV, resulting in a mortality rate of up to 100%, and there are currently no effective treatment methods or commercially available vaccines. Therefore, identifying host cell biochemical substances that can impede ASFV replication is crucial for the prevention and control of African swine fever. ASFV promotes self - replication by hijacking the metabolic mechanisms and biochemical resources of host cells, especially in the utilization of glucose and glutamine, which are the main metabolic sources of mammalian cells. The study found that ASFV infection promotes the use of glutamine by host cells to support virus self - replication. By blocking glutamine metabolism, ASFV replication can be significantly inhibited. In particular, after late - stage ASFV infection, the expression of phenyllactic acid in host cells increased significantly, which led to a severe disruption of the normal glutamine metabolic pathway. Pretreatment with phenyllactic acid not only inhibited the proliferation of ASFV but also reduced the consumption of glutamine. In addition, phenyllactic acid pretreatment also significantly slowed down the metabolism of glutamine - dependent amino acids and nucleotides. The reduction of these components directly hindered the replication of ASFV progeny viruses because they are the biosynthetic precursors required for virus replication. In conclusion, this study reveals that phenyllactic acid can impede the infectivity of ASFV by interfering with the host's glutamine metabolic pathway, and this finding provides a new direction for the development of antiviral drugs against ASFV.